| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | AbbVie Inc. | $216.63 | -2.1% | $383.17B | 91.4 | -1.4% | 3% | Healthcare | 16.8% | 8.6% | ||
| 2 | Novo Nordisk A/S | $43.19 | -0.8% | $191.93B | 12.2 | 16.8% | 4.1% | Healthcare | -41.6% | 8.1% | ||
| 3 | Amgen Inc. | $337.60 | -1.2% | $182.2B | 23.7 | 31.1% | 2.8% | Healthcare | 16.6% | 9.1% | ||
| 4 | Gilead Sciences, Inc. | $123.76 | -1.3% | $153.66B | 18.3 | 54.5% | 2.6% | Healthcare | 14.6% | 3.5% | ||
| 5 | Biogen Inc. | $196.58 | -1.1% | $29.02B | 22.3 | -7.8% | — | Healthcare | 55.4% | 0.4% | ||
| 6 | Scilex Holding Company | $7.47 | 5.2% | $63M | -0.2 | -148.5% | — | Healthcare | 55.9% | -33.2% |